Short-term symptomatic treatment of congestive suffering of the rhino-pharynx in cases of rhinitis, sinusitis, colds, otitis media.
Ephedrinum anhydricum 7.5 mg - eucalypti aetheroleum - Levomentholum - Paraffinum liquidum qs ad 1 g. Endrin
Ephedrinum anhydricum 5 mg - eucalypti aetheroleum - Paraffinum liquidum qs ad 1 g.
Nose drops, solution.
Posology and method of administration:
Endrin Sweet: each drop contains 0.2 mg of ephedrine .
Endrin: each drop contains 0.3 mg of ephedrine.
Adults and children over 12 years: to the 4 - 6 hours, 2 to 3 drops of Endrin Endrin Soft in each nostril. Not more than 15 drops a day.
If the sensitive mucous membranes, preferably using soft Endrin.
Children 6 to 12 years: 1 to 2 drops Endrin Soft in each nostril every 4 to 6 hours. Not more than 15 drops a day.
Endrin Endrin Soft or not administered to children younger than 6 years.
The total treatment duration limited to a few days. The administration stop once the symptoms have disappeared. If the symptoms do not improve after 3 to 4 days, a review be conducted.
To Endrin Endrin Soft or instilling the head if possible and then bend back to the left and right bending.
This is a medicine, no prolonged use without medical advice, keep away from children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.
Children younger than 6 years.
Closed angle glaucoma.
Known hypersensitivity to ephedrine or other sympathomimetics.
Coadministration of monoamine oxidase inhibitors or administration within the fourteen days following the discontinuation of treatment with a monoamine oxidase inhibitor.
Special precautions for use:
The administration of endrin or endrin Soft useless not renew because of the risk of rebound nasal congestion phenomena.
Endrin and Endrin Soft used with caution in patients with increased risk of complications or side effects due to the sympathomimetic effects of ephedrine, especially in cases of hyperthyroidism, hypertension, arterial aneurysm, pheochromocytoma, cardiac arrhythmias or ischemic myocardlijden.
Endrin Endrin Soft or not with a monoamine oxidase inhibitors or within 14 days following the cessation of such treatment. Endrin Endrin or not with a soft beta-blocker, the effect of these products can be eliminated and this can lead to a hypertension attack.
Endrin Endrin Soft or not use in newborns, infants and children younger than 6 years because the risk of overdose, which may be associated with a depression of the central nervous system.
Taking into account that soft Endrin and Endrin may induce a positive response from the tests carried out under the anti-doping controls.
Use during pregnancy and breastfeeding:
It is possible that
Endrin Endrin or soft passes the placental barrier and is excreted in breast milk. Consequently, the use of endrin or endrin Soft discouraged during the entire duration of pregnancy and during lactation.
irritation, feeling of dryness in the nose.
Risk on drug rhinitis and secondary hyperaemia which may lead to atrophy of the neusmucosa.
Risk of lipoid pneumonia due to the composition of the oily solution or Endrin Endrin Soft.
Reduced activity of the nasal cilia.
Systemic: Repeated use can expose exceptional:
Cardiovascular system: arterial hypertension, cardiac arrhythmias.
central nervous system: agitation, insomnia, headache, paleness and tremors, especially in young children and elderly.
The micturition is difficult in cases of prostatic hypertrophy.
Driving a vehicle and using machines:
Endrin Endrin not have an impact on the soft driving or operating machinery.
Overdose, emergency treatment and antidotes:
Given the low concentration of ephedrine (0.3 mg / drop and 0.2 mg Endrin / Endrin Soft drop) is unlikely that the administration even of large quantities of Endrin Endrin Soft leads to intoxication.
In case of accidental ingestion of high doses, the following symptoms: hypertension, cardiac arrhythmias, headache, vomiting, tremors, muscle weakness, rare suppression of the central nervous system, which may even evolve to coma.
In cases of severe reactions, hospitalize the patient.
If a hypertension attack, a fast-acting antihypertensive IV injection as phentolamine in a dose of 2 to 5 mg or 1 mg in the adult in the child. A reflex bradycardia can be prevented or suppressed by atropine. Tachy-arrhythmia treated by a beta-blocker.
Interaction with other medicinal products and other forms of interaction:
During concomitant use may Endrin Endrin or soft the rising blood pressure effects of other sympathomimetic amines reinforcing.
Endrin Endrin Soft or not associate with monoamine oxidase inhibitors, adrenolytic drugs, tricyclic antidepressants, beta-blockers or methyldopa because of the risk of hypertension attack. Soft or Endrin Endrin not administer within 14 days following the discontinuation of treatment with a monoamine oxidase inhibitor.
|Type of product||Medicine|